E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/20/2006 in the Prospect News Biotech Daily.

DNAPrint Genomics awarded patent for identifying links between gene sequences, medical traits

By Elaine Rigoli

Tampa, Fla., April 20 - DNAPrint Genomics, Inc. has received a notice of allowance from the U.S. Patent and Trademark Office for a patent application, "Methods for the Identification of Genetic Features for Complex Genetics Classifiers."

The patent protects the company's methods for identifying links between gene sequences and phenotypes (physical or medical traits), according to a news release.

"Gene sequences are highly polymorphic in the population, which means that they come in various forms or 'flavors,'" founder and chief scientific officer Tony N. Frudakis said in the release.

"Polymorphism is usually measured at the level of the single nucleotide polymorphism (SNP) but our technology measures at the level of the haplotype (strings of SNPs), which provides researchers considerably more information. The methods covered in the patent allow for an efficient and powerful means for identifying haplotype."

The company sad it will be reviewing products with its patent counsel to determine potential areas of development.

Based in Sarasota, Fla., DNAPrint Genomics is a developer of genomics-based products and services in the biomedical and forensics markets.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.